Please select the option that best describes you:

Is there evidence of clinical benefit to proceeding with partial pleurectomy / decortication over palliative chemotherapy with BSC (pleurex catheter, pleurodesis) in a patient with mesothelioma who is not a candidate for extra-pleural pneumectomy?  

What factors influence your decisions to offer neoadjuvant chemotherapy?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more